Loading...
XJPX
8129
Market cap2.32bUSD
Sep 22, Last price  
5,524.00JPY
1D
-0.16%
1Q
17.61%
Jan 2017
136.32%
IPO
1,389.46%
Name

Toho Holdings Co Ltd

Chart & Performance

D1W1MN
P/E
17.33
P/S
0.23
EPS
318.69
Div Yield, %
0.49%
Shrs. gr., 5y
-2.16%
Rev. gr., 5y
3.74%
Revenues
1.52t
+2.83%
706,488,000,000773,441,000,000805,414,000,000838,949,000,0001,002,112,000,0001,059,581,000,0001,108,144,000,0001,140,357,000,0001,189,624,000,0001,162,114,000,0001,308,358,000,0001,231,175,000,0001,213,322,000,0001,222,195,000,0001,263,769,000,0001,210,334,000,0001,266,171,000,0001,388,565,000,0001,476,712,000,0001,518,495,000,000
Net income
19.84b
-3.94%
3,612,000,0007,218,000,0008,381,000,000-2,471,000,0008,263,000,0007,283,000,00010,766,000,00011,526,000,00010,407,000,00013,535,000,00021,771,000,00014,225,000,00014,384,000,00013,863,000,00016,230,000,0004,989,000,00013,379,000,00013,630,000,00020,657,000,00019,844,000,000
CFO
-26.68b
L
4,613,000,00024,273,000,000-12,996,000,0009,963,000,0001,998,000,0009,726,000,00019,366,000,00024,558,000,000-18,636,000,00029,347,000,0002,381,000,00016,062,000,00051,978,000,00013,428,000,00010,815,000,0008,768,000,00016,341,000,000-9,000,00059,934,000,000-26,675,000,000
Dividend
Sep 29, 202545 JPY/sh

Profile

Toho Holdings Co., Ltd. engages in the wholesale distribution of pharmaceutical products in Japan. It sells prescription pharmaceuticals, reagents, medical devices and materials, OTC drugs, health foods, preventive care, clinical care, community healthcare linkage, and home medical and nursing care, as well as provides support services, including the development and sale of customer support systems, assistance in the start-up of medical institutions and pharmacies, management consulting services, medical support, and personnel recruitment. The company also engages in dispensing pharmacy business; manufacture and sale of generic drugs; and site management organization business that assists various medical institutions with clinical trials under contract, as well as sells software to medical institutions. In addition, it provides various customer support systems, including ENIF, an information terminal for pharmaceutical ordering; ENI-Pharmacy, a support system for the separation of dispensing and prescribing functions; LXMATE HeLios a medical care appointment system; KAITOS, an online medical consultation and medication guidance system; ENIFwin, an inventory control system for large hospitals; ENIFvoice SP/ ENIFvoice SP + A/ ENIFvoice Core, a supporting system for electronic medication history recording with voice recognition; and ENIF Nurse, an operation support terminal for home-visit nurses; and logistics systems. The company was incorporated in 1948 and is headquartered in Tokyo, Japan.
URL
https://www.tohohd.co.jp/
IPO date
Dec 11, 2002
Employees
7,699
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
1,518,495,000
2.83%
1,476,712,000
6.35%
1,388,565,000
9.67%
Cost of revenue
1,491,170,000
1,449,002,000
1,279,175,000
Unusual Expense (Income)
NOPBT
27,325,000
27,710,000
109,390,000
NOPBT Margin
1.80%
1.88%
7.88%
Operating Taxes
8,199,000
10,113,000
6,769,000
Tax Rate
30.01%
36.50%
6.19%
NOPAT
19,126,000
17,597,000
102,621,000
Net income
19,844,000
-3.94%
20,657,000
51.56%
13,630,000
1.88%
Dividends
(3,017,000)
(2,235,000)
(2,187,000)
Dividend yield
0.97%
0.85%
1.23%
Proceeds from repurchase of equity
(15,004,000)
(12,002,000)
(4,267,000)
BB yield
4.83%
4.56%
2.41%
Debt
Debt current
2,897,000
1,126,000
30,393,000
Long-term debt
20,937,000
30,644,000
9,108,000
Deferred revenue
6,000
10,104,000
Other long-term liabilities
11,572,000
11,103,000
1,396,000
Net debt
(127,953,000)
(171,925,000)
(128,374,000)
Cash flow
Cash from operating activities
(26,675,000)
59,934,000
(9,000)
CAPEX
(5,757,000)
(2,505,000)
(2,519,000)
Cash from investing activities
(4,180,000)
9,091,000
4,315,000
Cash from financing activities
(20,364,000)
(22,195,000)
(13,060,000)
FCF
(19,374,000)
55,744,000
92,654,000
Balance
Cash
86,533,000
132,970,000
86,201,000
Long term investments
65,254,000
70,725,000
81,674,000
Excess cash
75,862,250
129,859,400
98,446,750
Stockholders' equity
244,912,000
235,130,000
445,095,000
Invested Capital
214,462,750
160,921,600
188,704,250
ROIC
10.19%
10.07%
57.12%
ROCE
9.06%
9.14%
36.42%
EV
Common stock shares outstanding
69,699
72,028
75,369
Price
4,460.00
22.12%
3,652.00
55.40%
2,350.00
27.03%
Market cap
310,857,861
18.18%
263,047,399
48.52%
177,117,371
24.98%
EV
183,020,861
91,226,399
277,054,371
EBITDA
33,404,000
34,224,000
115,803,000
EV/EBITDA
5.48
2.67
2.39
Interest
46,000
145,000
72,000
Interest/NOPBT
0.17%
0.52%
0.07%